SILVER SPRING, Md. — Currently, there are at least four major published studies from around the world that indicate a link between the use of Zofran by pregnant women to inhibit morning sickness and development of serious birth defects in their babies. The studies took place in Europe, North America and Australia and reviewed pregnancy records from 1997 to 2012. All four studies demonstrated that women who used the anti-nausea drug Zofran during their pregnancy were more likely to give birth to children with major defects.

All four studies also reviewed the effect of the active ingredient in Zofran – ondansetron – in pregnant women. The United States study, which was sponsored by the U.S. Centers for Disease Control and Prevention, concluded that babies who were exposed to ondansetron in the womb were over twice as likely to develop cleft palates. In a study from the University of Western Australia, nearly 100,000 birth and pregnancy records were examined from children born between 2002 and 2005, and the results showed that ondansetron use increased the risk of severe birth defects by a shocking 20%, including high risks of kidney problems. A Danish study extends all the way from 1997 through 2010 and included over 900,000 pregnancies. The Danish results show that women who took ondansetron were nearly five times as likely to have children with “atrioventricular septal defect,” and there was also an increased risk for these children to develop other usually rare heart defects. A similar Swedish study reviewed birth records from 1998 to 2012 and found a 62% increase in the chance of babies developing congenital heart defects when their mothers took ondansetron during their pregnancy.

Although Zofran has been approved by the U.S. Food and Drug Administration since 1991, it is only supposed to be used in cancer patients and people recovering from surgery for their nausea. Nevertheless, doctors have been prescribing it for off-label use to treat severe morning sickness. In the wake of such unfortunate studies, many U.S. mothers have brought lawsuits against the manufacturer of Zofran, GlaxoSmithKline, for the defects their children have suffered. Many of the lawsuits allege that GSK was aware of the severe risks of birth defects but did not disclose them; instead, the lawsuits allege, GSK marketed the drug for use by women experiencing morning sickness. The U.S. Department of Justice has also alleged that GlaxoSmithKline marketed their anti-nausea drug specifically for use in women who experience serious morning sickness during their pregnancies.

Our Zofran Lawyers Can Help You

Our Zofran lawsuit attorneys can help if your child was harmed by this dangerous drug.   Lawsuits will be filed against the drug maker for injuries caused by to babies. You and your child may be entitled to a settlement. We do not charge any legal fees unless you receive a settlement and we pay all of the case costs. If your claim is not successful for any reason, you do not owe us anything. We put it in all in writing for you. Our Zofran lawyers will help you file your lawsuit.

Our No Fee Promise on Zofran Cases

You can afford to have our great team of lawyers on your side. When you choose us, it literally costs nothing to get started. We promise you in writing:

  • No money to get started
  • We pay all case costs and expenses
  • No legal fees whatsoever unless you receive a settlement
  • Phone calls are always free.

Start Your Zofran Lawsuit

Our Zofran lawyers will help you file your lawsuit. To get started, you can:

  1. Submit the Free Case Review Box on this page, or
  2. Call (866) 280-4722 any time of day to tell us about your case.

We will listen to your story and answer your questions. If you have claim, we will start immediately.

WARNING: There are strict time deadlines for filing Zofran lawsuit claims.